Lysosome metabolism and its link to protein cleanup, aging, and Alzheimer’s tau changes

Lysosomal NADPH metabolism regulates proteostasis, aging and tauopathy

NIH-funded research Baylor College of Medicine · NIH-11167842

Explores whether changes in a cell compartment called the lysosome help cells clear damaged proteins and reduce Alzheimer’s-related tau problems for people at risk of Alzheimer’s.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine NIH-funded
Lab location1 site (Houston, United States)
Project IDNIH-11167842 on NIH RePORTER

What this research studies

This research uses laboratory models to study how lysosomes — parts of cells that break down waste — control protein balance as we age and how that relates to Alzheimer’s changes, especially abnormal Tau protein. The team combines experiments in tiny worms, Alzheimer-model mice, and cell systems to trace a signaling pathway from lysosomal NADPH metabolism to protein quality control in the endoplasmic reticulum. By mapping these molecular steps, they aim to identify biochemical points that could be targeted to keep brain proteins from aggregating. The work is laboratory-focused and seeks findings that could guide future therapies or prevention strategies for Alzheimer’s.

Who could benefit from this research

Good fit: Findings would be most relevant to people with or at risk for Alzheimer’s disease, including those with mild cognitive impairment or a family history of Alzheimer’s.

Not a fit: Because this is preclinical laboratory research, it does not offer immediate treatments or patient interventions for people seeking current therapy.

Why it matters

Potential benefit: If successful, this could reveal new biological targets to protect brain cells, potentially leading to therapies that slow or prevent Alzheimer’s-related protein buildup.

How similar studies have performed: Prior preclinical studies have shown that improving lysosomal function can enhance protein clearance in cell and animal models, but these approaches have not yet produced proven human treatments.

Where this research is happening

Houston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer disease prevention
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.